Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group.

Lancet. 2013 Mar 9;381(9869):805-16. Erratum in: Lancet. 2013 Mar 9;381(9869):804.

2.

G protein-independent stimulation of human myocardial phospholipase C by mastoparan.

Schnabel P, Gäs H, Nohr T, Böhm M.

Br J Pharmacol. 1997 Sep;122(1):31-6.

3.

Identification and characterization of G protein-regulated phospholipase C in human myocardium.

Schnabel P, Gäs H, Nohr T, Camps M, Böhm M.

J Mol Cell Cardiol. 1996 Dec;28(12):2419-27.

PMID:
9004159
4.

Post-craniotomy staphylococcal infections following drainage with the Hemovac system.

Wilson FM, Federman MJ, Gas HH, Lerner AM.

Mich Med. 1974 Nov;73(32):671-4. No abstract available.

PMID:
4444550
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk